Cite
HARVARD Citation
Zheng, A. et al. (2018). The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India. Journal of the International AIDS Society. 21 (3), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zheng, A. et al. (2018). The cost‐effectiveness and budgetary impact of a dolutegravir‐based regimen as first‐line treatment of HIV infection in India. Journal of the International AIDS Society. 21 (3), p. n/a. [Online].